Most Popular
-
1
Ador CEO denies allegations, accuses Hybe of mistreating NewJeans
-
2
[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'
![[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/24/20240424050844_0.jpg&u=20240424200058)
-
3
Nicaragua shuts down Seoul embassy
-
4
Medical reform committee kicks off despite boycott from doctors
-
5
10-man S. Korea lose to Indonesia to miss out on Paris Olympic football qualification
![[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/24/20240424050844_0.jpg&u=20240424200058)
-
6
Rocket engine expert, ex-NASA exec to lead Korea's new space agency
-
7
SK hynix pledges W20tr to ramp up DRAM production at home
-
8
DP leader says he will meet Yoon without conditions
-
9
Over 9,000 hotline calls made by stalking victims in 2023
-
10
[Hello India] Hyundai Motor vows to boost 'clean mobility' in India
![[Hello India] Hyundai Motor vows to boost 'clean mobility' in India](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/25/20240425050672_0.jpg&u=)
![[Hello India] Hyundai Motor vows to boost 'clean mobility' in India](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/25/20240425050672_0.jpg&u=)
Vivozon’s new painkiller completes clinical trial phase 2a in US
By 황유미Published : Sept. 7, 2016 - 17:10
[THE INVESTOR] Vivozon’s VVZ-149, a nonopioid analgesics, has completed the 2a phase of clinical trials in the US, according to its largest stakeholder Telcon on Sept. 7.
The drug development venture was established in 2008 and its painkiller candidate is currently under phase 2b of clinical trials in the country. In the US the company has finished preparation for the phase 2b.
Telcon and its subsidiary KPM Tech will further increase their stakes in Vivozon and seek to diversify into biopharmaceutical business.
By Hwang You-mee (glamazon@heraldcorp.com)
The drug development venture was established in 2008 and its painkiller candidate is currently under phase 2b of clinical trials in the country. In the US the company has finished preparation for the phase 2b.
Telcon and its subsidiary KPM Tech will further increase their stakes in Vivozon and seek to diversify into biopharmaceutical business.
By Hwang You-mee (glamazon@heraldcorp.com)
![[Today’s K-pop] NewJeans' single teasers release amid intrigue](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/04/26/20240426050575_0.jpg&u=)